Press Releases
Search
-
09 Nov 2018
bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market
bioMérieux, a world leader in the field of in vitro diagnostics, today announces the acquisition of a majority holding in Suzhou Hybiome Biomedical Engineering Co.Ltd. This announcement follows the ac...
-
18 Oct 2018
Business review for the nine months ended September 30, 2018
Strong sales dynamic confirmed in third quarter, with an 8.8% increase in organic sales Growth of 9.8% at constant exchange rates and scope of consolidation over the nine months ended September 30: €1...
-
25 Sep 2018
bioMérieux commitments in the CDC’s “AMR Challenge”, a joint public-private sector initiative to accelerate the fight against antimicrobial resistance
Marcy l’Étoile (France) – Sept. 25, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, is participating in the AMR Challenge, a new Centers for Disease Control and Prevention (CDC...
-
05 Sep 2018
First-Half 2018 Results
Strong sales dynamic, with sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Contributive operating income before no...
-
18 Jul 2018
Second-Quarter 2018 Business Review
Strong sales dynamic confirmed in second quarter, leading to sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Growt...
-
12 Jun 2018
NEPHROCHECK® Biomarkers TIMP-2 and IGFBP7 Included in Acute Dialysis Quality Initiative Recommendations
The biomarkers in the NEPHROCHECK® test, an FDA-cleared and CE-marked urine test that indicates kidney stress in advance of acute kidney injury (AKI), have been included in a second set of consensus r...
-
31 May 2018
bioMérieux launches ENDOZYME® II GO, an innovative test for the detection of endotoxins in pharmaceutical microbiology control
bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of ENDOZYME® II GO, a new endotoxin test in the bioMérieux ENDONEXTTM range of recombinant horseshoe...
-
02 May 2018
NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in Groundbreaking Consensus Statement of Best Practices to Enhance Recovery after Heart Surgery
Marcy l’Étoile (France) and San Diego (California) - May 2nd, 2018 – The biomarkers in the NEPHROCHECK test, an FDA-cleared and CE-marked urine test that indicates kidney stress in advance of acute ki...
-
23 Apr 2018
bioMérieux and the University of Antwerp award scholarships to three healthcare professionals for their commitment to improve antibiotic use in order to combat antimicrobial resistance
Marcy l'Étoile (France) – Antwerp (Belgium) – April 23, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, and the Laboratory of Medical Microbiology at the University of Antwerp ...
-
19 Apr 2018
bioMérieux submits for FDA Clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel
bioMérieux, a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clear...
-
19 Apr 2018
bioMérieux – First-Quarter 2018 Business Review
Strong sales dynamic in first-quarter 2018, with sales up 12.5% at constant exchange rates and scope of consolidation: €587 million in sales Up 3.4% as reported Growth driven by molecular biology in t...
-
04 Apr 2018
bioMérieux reinforces its offering of High Medical Value immunoassay biomarkers with the acquisition of Astute Medical
bioMérieux, a world leader in the field of in vitro diagnostics, announces today the acquisition of Astute Medical Inc., a company dedicated to improving the diagnosis of high-risk medical conditions ...
-
28 Feb 2018
2017 Financial Results
Excellent sales momentum in 2017 with a 10.2% increase in sales, at constant exchange rates and scope of consolidation: €2,288 million in sales Up 8.8% as reported Strong 12.4% increase in contributiv...
-
23 Jan 2018
bioMérieux – Fourth-Quarter 2017 Business Review
Excellent sales momentum in 2017 with 10.2% growth in sales, at constant exchange rates and scope of consolidation: €2,288 million in sales Up 8.8% as reported Growth underpinned by all strategic prod...
-
15 Jan 2018
CNES and bioMérieux extend their collaboration on Aquapad, a unique water quality testing tool
Monday 15 January in Marcy l’Étoile (near Lyon), Proxima mission astronaut Thomas Pesquet detailed, during a conference, lessons learned from the Aquapad experiment he performed on the International S...